Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -70.00% vs 25.00% in Mar 2024
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 373.63% vs -39.20% in Mar 2024
Compare Balance Sheet Results of Biogen Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
65.26
13.65
51.61
378.10%
Share Warrants & Outstandings
Total Reserve
-9.03
15.94
-24.97
-156.65%
Shareholder's Funds
91.93
29.59
62.34
210.68%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.63
-0.63
-100.00%
Secured Loans
0
0.63
-0.63
-100.00%
Unsecured Loans
0
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
-0.05
0.05
100.00%
Other Long Term Liabilities
0.09
0.00
0.09
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
0.58
-0.58
-100.00%
Current Liabilities
Trade Payables
0.00
2.31
-2.31
-100.00%
Other Current Liabilities
0.00
0.17
-0.17
-100.00%
Short Term Borrowings
0.00
2.22
-2.22
-100.00%
Short Term Provisions
0.00
0.20
-0.20
-100.00%
Total Current Liabilities
0.18
4.90
-4.72
-96.33%
Total Liabilities
92.02
35.07
56.95
162.39%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.00
1.16
-1.16
-100.00%
Less: Accumulated Depreciation
0.00
0.18
-0.18
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
0.98
-0.98
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0
1.00
-1.00
-100.00%
Long Term Loans & Advances
65.50
29.85
35.65
119.43%
Other Non Current Assets
0.00
2.00
-2.00
-100.00%
Total Non-Current Assets
0.57
33.83
-33.26
-98.32%
Current Assets Loans & Advances
Current Investments
23.84
0.00
23.84
0.00%
Inventories
0.00
0.00
0.00
0.00%
Sundry Debtors
0.00
0.33
-0.33
-100.00%
Cash and Bank
2.02
0.28
1.74
621.43%
Other Current Assets
0
0.01
-0.01
-100.00%
Short Term Loans and Advances
0.00
0.62
-0.62
-100.00%
Total Current Assets
25.86
1.24
24.62
1,985.48%
Net Current Assets (Including Current Investments)
25.68
-3.65
29.33
803.56%
Total Current Assets Excluding Current Investments
2.02
1.24
0.78
62.90%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
92.02
35.07
56.95
162.39%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
2.85
-2.85
-100.00%
Book Value per share (adjusted)
0.86
21.68
-20.82
-96.03%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -70.00% vs 25.00% in Mar 2024
Annual - Fixed Assets
No Fixed Assets in the last few periods
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 373.63% vs -39.20% in Mar 2024
